{"sourcedb":"DevicePMAs@therightstef","sourceid":"P010049_S011","text":"Approval to add thrombin to the hemostatic pledget.  The device, as modified, will be marketed under the trade name quickseal surestat arterial closure system and is indicated for \" of t-foam for extravascular closure of the femoral artery access sites.  The system is indicated for use in reducing time to hemostasis at femoral artery puncture sites and in reducing time to ambulation in patients who have undergone diagnostic or interventional procedures using 8 french or smaller procedural sheaths.  The device reduces time to eligibility for hospital discharge in patients who have undergone diagnostic or interventional procedures and reduces time to actual hospital discharge in patients who have undergone diagnostic procedures.\"","project":"consensus_PMA_Age_Indications"}